Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova
STOCKHOLM, April 23, 2021 /PRNewswire/ -- Sweden's innovation authority Vinnova is investing in Lipidor's subsidiary Emollivet. The funding from Vinnova is for SEK 300,000 and will be used for a project in which Emollivet, through interaction with animal owners and others in the animal health mark...
2021-04-23 15:22
1795
Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology
STOCKHOLM, Sept. 30, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North:LIPI) today announces a positive outcome of the feasibility study into the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The study was conducted in collabor...
2020-09-30 15:44
3046
